Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Lymphocytic, Small; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Ritcher's Transformation, Syndrome Intervention: Drug: Pirtobrutinib Sponsor: Loxo Oncology, Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Leukemia | Lymphoma | Macroglobulinemia | Research | Waldenstrom's Macroglobulinemia